tetraethylammonium has been researched along with wortmannin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Paterson, WG; Zhang, Y | 1 |
Craciun, LC; Jin, T; Logothetis, DE; Lopes, CM; Mirshahi, T; Rohács, T; Zhang, H | 1 |
Barnes, KR; Cantley, L; Josephson, L; Weissleder, R; Yuan, H | 1 |
Chen, QM; Sheveleva, E; Sun, H; Xu, B | 1 |
4 other study(ies) available for tetraethylammonium and wortmannin
Article | Year |
---|---|
Role of Ca2+-activated Cl- channels and MLCK in slow IJP in opossum esophageal smooth muscle.
Topics: Androstadienes; Animals; Anthracenes; Azepines; Calcium; Chloride Channels; Electrophysiology; Enzyme Inhibitors; Esophagus; Female; Ileum; Indomethacin; Male; Membrane Potentials; Muscle, Smooth; Myosin-Light-Chain Kinase; Neural Inhibition; Neuromuscular Junction; Niflumic Acid; Opossums; Tetraethylammonium; Wortmannin | 2002 |
PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents.
Topics: Androstadienes; Animals; Bradykinin; Cells, Cultured; CHO Cells; Cricetinae; Electric Conductivity; Enzyme Inhibitors; Female; Hydrolysis; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Microscopy, Confocal; Mutation; Neurons; Patch-Clamp Techniques; Phosphatidylinositol 4,5-Diphosphate; Phosphoinositide-3 Kinase Inhibitors; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Recombinant Proteins; Second Messenger Systems; Signal Transduction; Superior Cervical Ganglion; Tetraethylammonium; Transfection; Wortmannin; Xenopus laevis | 2003 |
Covalent reactions of wortmannin under physiological conditions.
Topics: Amino Acids; Androstadienes; Dimethyl Sulfoxide; Drug Stability; Kinetics; Molecular Conformation; Mycotoxins; Solvents; Tetraethylammonium; Wortmannin | 2007 |
LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.
Topics: Androstadienes; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Chromones; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Induction; Glucocorticoids; Morpholines; Myocytes, Cardiac; Nimodipine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Tetraethylammonium; Time Factors; Wortmannin | 2008 |